Previous 10 | Next 10 |
Mirion Technologies, Inc. (“Mirion,” “we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the pricing of an...
Mirion Technologies ( NYSE: MIR ) on Thursday announced the commencement of an underwritten public offering by certain selling stockholders. The selling stockholders are offering 9,786,153 shares of Mirion’s class A common stock. The selling stockholders participating ...
Mirion Technologies, Inc. (“Mirion,” “we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the commencement ...
Mirion Technologies ( NYSE: MIR ) received $150M investment from funds and accounts advised by T. Rowe Price ( TROW ) Investment Management through the acquisition of 17.1M Mirion shares at $8.75/share. The transaction is expected to close on Feb.23, 2023. The company plan...
Funds and accounts advised by T. Rowe Price Investment Management, Inc. invest $150 million in Mirion to acquire 17,142,857 shares of Mirion common stock at $8.75 per share. Mirion intends to use approximately $125 million to pay down debt, with a target net leverage ratio of ~3.1x by...
HALIFAX, NS / ACCESSWIRE / February 20, 2023 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announces the singing of a multinational distribution agreement with Maternova, Inc. , Rhode Island, USA. Maternova is a US-based distribution company specialising in maternal and infant he...
Mirion Technologies, Inc. (MIR) Q4 2022 Earnings Conference Call February 14, 2023, 10:00 AM ET Company Participants Alex Gaddy - Vice President, Head, Strategy and Corporate Development Larry Kingsley - Chairman of the Board Tom Logan - Chief Executive Officer Bri...
The following slide deck was published by Mirion Technologies, Inc. in conjunction with their 2022 Q4 earnings call. For further details see: Mirion Technologies, Inc. 2022 Q4 - Results - Earnings Call Presentation
Mirion Technologies press release ( NYSE: MIR ): Q4 Non-GAAP EPS of $0.11 misses by $0.01 . Revenue of $217.9M (+22.6% Y/Y) beats by $17.11M . 2023 Outlook: Reported revenue growth of 6% to 9%, organic growth of 4% to 7% Adjusted EBITDA of $172 million - $1...
Revenues for the fourth quarter increased 22.6% to $217.9 million, compared to $177.8 million in the same period in 2021. Adjusted revenues increased 20.5% compared to the fourth quarter of 2021. GAAP net loss was $159.7 million in the fourth quarter. Adjusted EBITDA was $56.4 million for...
News, Short Squeeze, Breakout and More Instantly...
Mirion Technologies Inc. Class A Company Name:
MIR Stock Symbol:
NYSE Market:
Mirion Technologies Inc. Class A Website:
HALIFAX, NS / ACCESSWIRE / July 2, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended April 30, 2024. Corporate update In Q3 FY2024, MedMira focused on the launch of MedMira's latest US FDA approved Reveal ® G4 Rapid HIV 1/2 antibody...
2024-06-23 05:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-13 06:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...